WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.

Abstract

The bone marrow criteria defined by the World Health Organization (WHO) are based on characteristic increase and clustering of morphologically abnormal enlarged megakaryocytes as a pathognomonic clue to describe three distinct phenotypic entities of myeloproliferative disorders (MPDs): (1) essential thrombocythemia (ET), (2) early and overt polycythemia… (More)

Topics

4 Figures and Tables

Cite this paper

@article{Michiels2007WHOBM, title={WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.}, author={Jan Michiels and Hendrik de Raeve and Konnie M. Hebeda and King H. Lam and Zwi Nisan Berneman and Wilfried A M Schroyens and Jiř{\'i} Schwarz}, journal={Leukemia research}, year={2007}, volume={31 8}, pages={1031-8} }